Epidermodysplasia verruciformis associated with HPV 10

Dermatology Online Journal

Volumn 19, Issue 4, 2013, Pages

  Zahir, Amir ^a   Craig, Lauren ^a   Rady, Peter ^b   Tyring, Stephen ^b   Ehrlich, Alison ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID NITROGEN; DNA PROBE; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; COMPUTER ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE DURATION; EPIDERMODYSPLASIA VERRUCIFORMIS; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 10; IN SITU HYBRIDIZATION; MALE; MICROSCOPY; PAPULE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PUNCH BIOPSY; SKIN DEFECT; VERRUCA PLANA JUVENILIS; VIRUS IDENTIFICATION; WART VIRUS; ALPHAPAPILLOMAVIRUS; COMPLICATION; DNA PROBE; GENETIC PREDISPOSITION; GENETICS; ISOLATION AND PURIFICATION; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; VIROLOGY; REVIEW;

ADULT; ALPHAPAPILLOMAVIRUS; DNA PROBES, HPV; DNA, VIRAL; EPIDERMODYSPLASIA VERRUCIFORMIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION; MALE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 84876244072     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nuovo G, Ishag M. The Histologic Spectrum of Epidermodysplasia Verruciformis. The American Journal of Surgical Pathology 2000; 24(10): 1400-1406. [PubMed]
2. Rogers HD, Macgregor JL, Nord KM, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 2009; 60(2): 315-320. [PubMed]
3. Gewirtzman A, Bartlett B, Tyring S. Epidermodysplasia verruciformis and human papilloma virus. Curr Opin Infect Dis 2008; 21: 141-146. [PubMed]
4. Patel T, Morrison K, Rady P, Tyring S. Epidermodysplasia verruciformis and susceptibility to HPV. Disease Markers 2010; 29: 199-206. [PubMed]
5. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33(3): 690-695. [PubMed]
6. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057-1062. [PubMed]
7. Gubinelli E, Posteraro P, Cocuroccia B, Girolomoni G. Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin. Journal of Dermatological Treatment 2003; 14: 184-188. [PubMed]
8. de Oliveira WR, et al. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 2003; 17(4): 394-398. [PubMed]
9. Sri J, Dubina M, Kao G, Rady P, Tyrking S, Gaspari A. Generalized Verrucosis: A Review of the associated diseases, evaluation, and treatments. J Am Acad Dermatol 2012; 66(2): 292-311. [PubMed]
10. de Sá NB, Guerini MB, Barbato MT, Di Giunta G, Nunes DH. Epidermodysplasia verruciformis: clinical presentation with varied forms of lesions. An Bras Dermatol 2011; 86(4 suppl 1): 57-60. [PubMed]
11. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 2002; 138(5): 649-654. [PubMed]
12. Kelesidis T, Aish L, Steller MA, et al. Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection. Am J Clin Pathol 2011; 136(1): 119-127. [PubMed]
13. Nuovo G. PCR In Situ Hybridization: Protocols and Applications, 3rd ed. New York, NY: Lippincott-Raven Press, 1997.
14. Lane JE, Bowman PH, Cohen DJ. Epidermodysplasia verruciformis. South Med J 2003; 96: 613-615. [PubMed]
15. Iraji F, Faghihi G. Epidermodysplasia verruciformis: association with isolated IgM deficiency and response to treatment with acitretin. Clin Exp Dermatol 2000; 25(1): 41-43. [PubMed]
16. Lutzner M, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatology 1984: 83(1) (suppl 1): 18-25. [PubMed]
17. Al Rubaie S, Breuer J, Inshasi J, Al Saady S, Fathi I. Epidermodysplasia verruciformis with neurological manifestations. Int J Dermatol 1998; 37(10): 766-771. [PubMed]
18. Rallis E, Papatheodorou G, Bimpakis E, Butanska D, Menounos P, Papadakis P. Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 2008; 22(4): 523-525. [PubMed]
19. Anadolu R, Oskay T, Erdem C, Boyvat A, Terzi E, Gurgey E. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon-2a. J Amer Acad Dermatol 2001; 45(2): 296-9. [PubMed]
20. Craven N, Griffiths C. Retinoids in the management of non-melanoma skin cancer and melanoma. Cancer Surv 1996; 26: 267-288. [PubMed]
21. Berthelot C, Dickerson M, Rady P, et al. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol 2007; 56(5): 882-886. [PubMed]
22. Baskan E, Tunali S, Adim S, Turan A, Toker S. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge. J Dermatolog Treat 2006; 17 (suppl 1): 179-183. [PubMed]
23. Micali G, Nasca M, Dall'Oglio F, Musumeci M. Cimetidine therapy for epidermodysplasia verruciformis. J Am Acad Dermatol 2003; 48(suppl 2): 9-10. [PubMed]
24. de Oliveira W, Neto C, Rivitti E. The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis. J Am Acad Dermatol 2004; 50(6): 14-15. [PubMed]
25. Karrer S, Szeimies R, Abels C, Wlotzke U, Stolz W, Landthaler M. Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 935-938. [PubMed]